From the blog

Pembrolizumab and Chemotherapy Improve Survival in Patients

Pleural mesothelioma, a cancer mainly caused by asbestos, is a hard cancer to treat. Diagnosis usually occurs when it is in a late stage, leading to limited treatment options. New clinical trials are always being performed to try to find a new treatment approach that could possibly extend the lives[…]

Read More »

CIRT Radiation Therapy Beneficial for Lung Cancer Patients

Surgery is usually the first choice for patients and doctors for the treatment of early-stage cancer. There are other options though like radiotherapy. A special type of radiotherapy called Carbon-ion radiotherapy (CIRT)has become popular with doctors.  A study in Japan showing how the therapy can benefit patients with early-stage lung[…]

Read More »

Checkmate743 Showed Higher Toxicity in a Real World Setting

A group of Australian patients receiving Checkmate743 therapy saw higher levels of toxicity compared to CheckMate743 clinical trial patients. Checkmate743 consists of a dual treatment of ipilimumab and nivolumab and is the standard of care for patients with unresectable pleural mesothelioma. Unresectable means patients are not able to receive surgery[…]

Read More »

A New Biomarker Could Help Doctors Diagnose Mesothelioma

A new biomarker has been found for the diagnosis of mesothelioma by scientists in Japan. Information from this research could revolutionize how mesothelioma is diagnosed and treated in the future. Mesothelioma is a hard cancer to diagnose because it shares symptoms with other cancers. Cancers it can look like include[…]

Read More »

Johnson & Johnson Will Try to File for Bankruptcy for a Third Time

Johnson & Johnson may try to file bankruptcy for a third time to address its talc liabilities. The company has failed twice before but is looking again to file for bankruptcy under a different corporate structure. There are around 51,000 lawsuits claiming that people who used Johnson & Johnson’s talc-based[…]

Read More »

Inhibiting YB-1 Can Help Improve Mesothelioma Treatments

Researchers in Vienna, Austria recently found a protein that could help treat mesothelioma patients. Researchers found the oncoprotein YB-1 which, when targeted, could make pleural mesothelioma more sensitive to chemotherapy and radiotherapy. The results of the study were published in the medical journal “Cancer Letters.” The study builds on earlier[…]

Read More »

Teachers in Philadelphia are Suing for Being Punished for Asbestos Protest

Three teachers recently filed a lawsuit over their first amendment right to publicly demand answers about asbestos inside classrooms.  They claim their rights were violated when they were punished for protesting in 2021. As part of a protest, they worked outside during teacher only workdays to protest their risks of[…]

Read More »

There are Stricter Regulations for Manufacturers of Asbestos

Now that the final reporting from the U.S. Environmental Protection Agency’s Toxic Substances Control Act is completed, asbestos manufacturers and processors are under stricter regulations. This is all due to the EPA mandating the reporting and record-keeping of uses of asbestos by companies that manufacture, import, or process asbestos or[…]

Read More »

Chemoimmunotherapy Benefits Pleural Mesothelioma Patients

Results from a phase 3 clinical trial were recently published in the Journal of Clinical Oncology showing that a combination of chemotherapy and immunotherapy for mesothelioma improves patients’ survival more than chemotherapy alone. Researchers combined Keytruda, or pembrolizumab, with platinum and pemetrexed chemotherapy. The overall response rate for patients receiving[…]

Read More »